FOXP3 and atherosclerosis: Our and others' reports demonstrated that CD4+Foxp3+ regulatory T cells play significant roles in suppressing immune responses, inflammations, atherosclerosis [13, 25–27, 70, 79–83], and antitumor immune reactions [84] and promoting tissue regeneration.